Biofrontera AG Sponsored ADR Gross Margin

Gross Margin of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Gross Margin growth rates and interactive chart. Gross profit margin shows the percentage of revenue that exceeds a company's costs of goods sold. It illustrates how well a company is generating revenue from the costs involved in producing their products and services. The higher the margin, the more effective the company's management is in generating revenue for each dollar of cost. Gross profit margin is calculated by subtracting the cost of goods sold from total revenue for the period and dividing that number by revenue. If a company has $200 million in revenue and $80 million in cost of goods sold, the gross margin is 60%.


Highlights and Quick Summary

  • Gross Margin for the quarter ending June 30, 2022 was 80.52% (a -3.08% decrease compared to previous quarter)
  • Year-over-year quarterly Gross Margin decreased by -7.46%
  • Annual Gross Margin for 2021 was 86.41% (a 14.54% increase from previous year)
  • Annual Gross Margin for 2021 was 75.44% (a -14.61% decrease from previous year)
  • Annual Gross Margin for 2020 was 88.35% (a 24.31% increase from previous year)
  • Twelve month Gross Margin ending June 30, 2022 was 84.95% (a -1.46% decrease compared to previous quarter)
  • Twelve month trailing Gross Margin decreased by -2.22% year-over-year
Trailing Gross Margin for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
84.95% 86.21% 86.37% 86.88%
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Gross Margin of Biofrontera AG Sponsored ADR

Most recent Gross Marginof BFAGY including historical data for past 10 years.

Interactive Chart of Gross Margin of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Gross Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 80.52% 83.08%
2021 88.36% 87.01% 85.41% 83.55% 86.41%
2020 89.82% 77.17% 92.82% 87.66% 88.35%
2019 94.41% 66.83% 85.86% 84.41%
2018 79.79% 78.91%
2017 88.64% 86.12% 85.74%
2016 100.0% 73.05%

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic